NANO MRNA previously had been a pharmaceutical venture company undertaking nanomedicine development based on micellar nanoparticle technology but changed in its business model to become an IP generator for mRNA therapeutics. The company will not undertake clinical trials on pipeline products but will focus on the nonclinical stage.